TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,806,000 | +2.6% | 132,500 | +23.3% | 0.04% | -30.2% |
| Q3 2021 | $1,761,000 | -2.7% | 107,500 | 0.0% | 0.05% | -17.2% |
| Q2 2021 | $1,809,000 | -7.8% | 107,500 | 0.0% | 0.06% | +30.6% |
| Q1 2021 | $1,963,000 | +2057.1% | 107,500 | +2050.0% | 0.05% | +2350.0% |
| Q4 2020 | $91,000 | +2.2% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $89,000 | -1.1% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $90,000 | -96.0% | 5,000 | -95.5% | 0.01% | -97.3% |
| Q1 2019 | $2,272,000 | – | 111,550 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |